Protocol for an implementation study of group metacognitive therapy for anxiety and depression in NHS cardiac rehabilitation services in England (PATHWAY-Beacons)
- PMID: 39483442
- PMCID: PMC11524926
- DOI: 10.3389/frhs.2024.1296596
Protocol for an implementation study of group metacognitive therapy for anxiety and depression in NHS cardiac rehabilitation services in England (PATHWAY-Beacons)
Abstract
Background: Cardiac rehabilitation (CR) services aim to improve heart disease patients' health and quality of life and reduce the risk of further cardiac events. Depression and anxiety are common among CR patients but psychological treatments have usually had small effects. In contrast, the recent NIHR-funded PATHWAY trial found that group Metacognitive Therapy (MCT) was associated with improvements in anxiety and depression when added to CR and was more effective than usual CR alone. The next stage is to test implementation of MCT within the National Health Service through the creation of a network of CR beacon sites. The study will test the quality of data capture following addition of a new MCT data-field to the national audit of cardiac rehabilitation (NACR), examine level of adoption at sites, examine mental health outcomes benchmarked against usual CR and the PATHWAY data, examine the enablers and barriers to implementation and the expected resource requirements. The study has been registered: NCT05956912 (13th July, 2023).
Methods: Beacon sites will be recruited as preliminary adopters of group MCT from NHS CR services in England. A national invitation for expressions of interest from CR services will be issued and those meeting eligibility criteria will be considered for inclusion. Two staff at each site will receive training in MCT, and mixed-methods will be used to address questions concerning the quality of patient data recorded, level of adoption at sites, the characteristics of patients attending MCT, the impact of adding MCT to CR on mental health outcomes, and patient, healthcare staff and commissioner views of barriers/enablers to implementation. Exploration of implementation will be informed by Normalisation Process Theory.
Discussion: The study will support development of an NHS roll-out strategy, assess the mental health outcomes associated with MCT, examine treatment fidelity in real-world settings, and evaluate revised data collection structures that can be used to assess the impact of national-level implementation.
Trial registration: NCT05956912; 13th July 2023.
Keywords: anxiety; cardiac rehabilitation; implementation; mental health; metacognitive therapy.
© 2024 Wells, Reeves, Belcher, Wilson, Doherty and Capobianco.
Conflict of interest statement
AW is the director of the MCT-Institute and developer of MCT. He has written books on cognitive behaviour therapy and MCT. He is chief investigator on grants; NIHR201495; NIHR35997, and co-CI on NIHR203634. LC is the chief investigator on NIHR203634, and PD is a co-applicant on grant NIHR203634. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Similar articles
-
Improving the effectiveness of psychological interventions for depression and anxiety in the cardiac rehabilitation pathway using group-based metacognitive therapy (PATHWAY Group MCT): study protocol for a randomised controlled trial.Trials. 2018 Apr 3;19(1):215. doi: 10.1186/s13063-018-2593-8. Trials. 2018. PMID: 29615092 Free PMC article.
-
Improving the Effectiveness of Psychological Interventions for Depression and Anxiety in Cardiac Rehabilitation: PATHWAY-A Single-Blind, Parallel, Randomized, Controlled Trial of Group Metacognitive Therapy.Circulation. 2021 Jul 6;144(1):23-33. doi: 10.1161/CIRCULATIONAHA.120.052428. Epub 2021 Jun 21. Circulation. 2021. PMID: 34148379 Free PMC article. Clinical Trial.
-
Metacognitive therapy home-based self-help for cardiac rehabilitation patients experiencing anxiety and depressive symptoms: study protocol for a feasibility randomised controlled trial (PATHWAY Home-MCT).Trials. 2018 Aug 16;19(1):444. doi: 10.1186/s13063-018-2826-x. Trials. 2018. PMID: 30115112 Free PMC article. Clinical Trial.
-
Evaluating Metacognitive Therapy to Improve Treatment of Anxiety and Depression in Cardiovascular Disease: The NIHR Funded PATHWAY Research Programme.Front Psychiatry. 2022 Jun 3;13:886407. doi: 10.3389/fpsyt.2022.886407. eCollection 2022. Front Psychiatry. 2022. PMID: 35722590 Free PMC article. Review.
-
Service design for children and young people with common mental health problems: literature review, service mapping and collective case study.Health Soc Care Deliv Res. 2024 May;12(13):1-181. doi: 10.3310/DKRT6293. Health Soc Care Deliv Res. 2024. PMID: 38767587 Review.
References
-
- World Health Organization (WHO). WHO Global NCD Action Plan 2013–2020 [Internet]. 2013 [cited 2023 12]. Available online at: https://www.who.int/nmh/events/ncd_action_plan/en/
-
- Meijer A, Conradi HJ, Bos EH, Thombs BD, van Melle JP, de Jonge P. Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis of 25 years of research. Gen Hosp Psychiatry. (2011) 33(3):203–16. 10.1016/j.genhosppsych.2011.02.007 - DOI - PubMed
Associated data
LinkOut - more resources
Full Text Sources
Medical